Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
News
Home > Company News > Renal Failure Conversion Support: Improving Pet Kidney Health Outcomes
2025-11-24
Chronic kidney disease (CKD) affects a significant portion of aging pets, with studies suggesting that over 30% of cats and 10% of dogs over 15 years old develop renal impairment. For B2B buyers in the pet health industry, providing effective nutritional solutions for renal support is not just a market opportunity—it's a clinical necessity. At Yipai Biotechnology, we've developed a targeted approach to renal health through our Veterinary Renal Support Vitamin D3 with Reishi Mushroom, specifically formulated to address the metabolic challenges in pets with compromised kidney function.
In healthy pets, kidneys convert vitamin D to its active form, calcitriol, which regulates calcium-phosphorus balance. However, in renal-impaired animals, this conversion capacity diminishes significantly, leading to:

Standard vitamin D formulations require renal conversion to become bioactive—precisely what failing kidneys cannot adequately perform. Our solution provides the active form directly, bypassing this metabolic bottleneck.
Each 100mL of our renal support liquid contains:
Produced in our FDA-registered facility (Registration No: 13323196228) following ISO 9001:2015 standards, this Clinical-Strength Pet Multivitamin represents pharmaceutical-grade quality for veterinary applications.
Our invention patent (202110933638.0) covers the unique extraction and stabilization of Reishi mushroom compounds, delivering:
Unlike standard supplements, our fresh meat enzymolysis technology predigests proteins into small-molecule peptides that:
While our Veterinary Renal Support Vitamin D3 addresses specific renal challenges, it functions within Yipai's broader product ecosystem. B2B partners can leverage our complete range of targeted formulations, including:
Based on extensive clinical application, we recommend:
Dosage can be adjusted based on disease severity and veterinary recommendation.
Our oral liquid format with included syringe enables multiple administration options:
With an annual production capacity of 4 million bottles across our semi-solid production lines, we guarantee:
Our 2,650㎡ facility features advanced quality assurance systems:
Our formulation is based on the established pathophysiology of renal secondary hyperparathyroidism and vitamin D metabolism in pets. The combination with Ganoderma lucidum is protected by our invention patent (202110933638.0) and has been validated through extensive veterinary clinical application across our partner network.
Three key differentiators: (1) Our formula provides vitamin D in a readily bioavailable form that bypasses impaired renal conversion; (2) The incorporation of patented Ganoderma lucidum extract provides additional immune and anti-inflammatory benefits; (3) Our fresh meat enzymolysis technology ensures optimal absorption even in pets with compromised digestive function.
We offer comprehensive OEM/ODM services through our 7-engineer R&D team, including formula customization, packaging design, and dosage adjustments. Our monthly production capacity of 20,000 units ensures we can accommodate both small test batches and large-volume orders.
We provide full FDA registration documentation (No: 13323196228), ISO 9001:2015 certificates, detailed ingredient specifications, and manufacturing process documentation to facilitate seamless import for our international partners.
Our renal support formula is designed as complementary therapy alongside conventional renal diets, phosphate binders, and other standard renal care protocols. It addresses the specific nutritional gap in vitamin D metabolism that other treatments don't cover.
We offer comprehensive technical documentation, client education materials, and clinical application guidelines. Our international trade team provides dedicated account management from inquiry through delivery and after-sales support.
With over 40 existing products, 6 software copyrights, and 20+ years of specialized focus on pet health, Yipai Biotechnology represents more than a supplier—we're a strategic innovation partner. Our membership in the China Commodity Coding Center and portfolio of 2 invention patents and 5 utility model patents demonstrates our commitment to scientifically-validated product development.
For B2B partners seeking reliable, clinically-relevant pet health solutions, our Veterinary Renal Support Vitamin D3 with Reishi Mushroom offers a scientifically-advanced approach to managing one of the most challenging conditions in veterinary medicine. Contact us to request samples, factory qualification documents, and discuss how we can support your renal health product portfolio.
Contact: Tel: 13213126669 | Email: 81953412@qq.com
Share to:
Send Inquiry
Mr. yan zhengquan
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.